San Diego, CANCT03992729Now EnrollingIRB Ready

Pregnancy Related Clinical Trial in San Diego, CA

Access cutting-edge pregnancy related treatment through this clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.

Sponsored by Sun Pharmaceutical Industries Limited

Quick Self-Assessment

See if you qualify for this San Diego location

Preparing your pre-screening questions…

Expert Care in San Diego

Access pregnancy related specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pregnancy related treatment provided free

Apply for This San Diego Location

Check if you qualify for this pregnancy related clinical trial in San Diego, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Diego

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Diego site if eligible
  4. 4Begin participation

About This Pregnancy Related Study in San Diego

This study will utilize a prospective, observational, exposure cohort design to examine pregnancy and infant outcomes in women and infants who are exposed to tildrakizumab during pregnancy to treat an approved indication. The pregnancy registry cohort study will be conducted by the Organization of Teratology Information Specialists (OTIS), which is a network of university and health department based information centers serving pregnant women and healthcare providers throughout North America. These services provide a basis for collaborative research such as this Registry. These Services located throughout the United States (US) and Canada will serve as a source of referrals not only for tildrakizumab-exposed pregnancies but also for similarly ascertained disease-matched comparison pregnant women who have not used tildrakizumab in pregnancy. The target follow-up period will be until end of pregnancy and 1 year of age for live born infants.

Sponsor: Sun Pharmaceutical Industries Limited

Who Can Participate

Inclusion Criteria

Cohort 1: Tildrakizumab-Exposed Cohort
Pregnant women
Exposure to tildrakizumab for the treatment of an approved indication, for any number of days, at any dose, and at any time from the first day of the last menstrual period up to and including the end of pregnancy
Agree to the conditions and requirements of the study including the interview schedule, and release of medical records Cohort 2: Disease-Matched Comparison Cohort
Pregnant women
Diagnosed with a tildrakizumab-approved indication; frequency matched to the exposed group by disease indication, with the indication validated by medical records when possible
No exposure to tildrakizumab at any time in the current pregnancy; may or may not have taken another medication for their disease in the current pregnancy
Agree to the conditions and requirements of the study including the interview schedule, and release of medical records Exclusion criteria: Cohort 1: Tildrakizumab-Exposed Cohort:
Women who have first contact with the project after prenatal diagnosis of any major structural defect
Women who have enrolled in the tildrakizumab cohort study with a previous pregnancy (women may only enroll once in the Tildrakizumab Pregnancy Study)
Women who have used tildrakizumab for an indication other than a currently approved indication
Retrospective enrollment after the outcome of pregnancy is known Cohort 2: Disease-Matched Comparison Cohort
Women who have first contact with the project after prenatal diagnosis of any major structural defect
Exposure to tildrakizumab anytime during the current pregnancy
Women who have enrolled in the tildrakizumab cohort study with a previous pregnancy (women may only enroll once in the Tildrakizumab Pregnancy Study)
Retrospective enrollment after the outcome of pregnancy is known

Exclusion Criteria

Cohort 1: Tildrakizumab-Exposed Cohort:
Women who have first contact with the project after prenatal diagnosis of any major structural defect
Women who have enrolled in the tildrakizumab cohort study with a previous pregnancy (women may only enroll once in the Tildrakizumab Pregnancy Study)
Women who have used tildrakizumab for an indication other than a currently approved indication
Retrospective enrollment after the outcome of pregnancy is known Cohort 2: Disease-Matched Comparison Cohort
Women who have first contact with the project after prenatal diagnosis of any major structural defect
Exposure to tildrakizumab anytime during the current pregnancy
Women who have enrolled in the tildrakizumab cohort study with a previous pregnancy (women may only enroll once in the Tildrakizumab Pregnancy Study)
Retrospective enrollment after the outcome of pregnancy is known

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Diego?

Yes, this clinical trial (NCT03992729) has an active research site in San Diego, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pregnancy Related Treatment Options in San Diego, CA

If you're searching for pregnancy related treatment options in San Diego, CA, this clinical trial (NCT03992729) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Diego research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pregnancy related specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pregnancy related clinical trials near you to find additional studies recruiting in your area.

More Erectile Dysfunction Trials in San Diego, CA

See all erectile dysfunction clinical trials recruiting in San Diego — not just this study.

Browse Erectile Dysfunction Trials in San Diego →

Browse More Trials by Condition

Erectile Dysfunction TrialsAll Conditions →

Ready to Join in San Diego?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Diego, CA